[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-001", "question": "A 14-year-old boy with juvenile idiopathic arthritis presents with acute onset of fever, rash, and joint swelling after starting etanercept therapy. Laboratory findings include elevated ferritin, pancytopenia, and hypertriglyceridemia. What is the most appropriate next step in management?", "options": ["Discontinue etanercept and initiate high-dose corticosteroids", "Administer intravenous immunoglobulin", "Start rituximab infusion", "Perform bone marrow biopsy immediately", "Initiate broad-spectrum antibiotics"], "answer": "A", "answer_index": 0, "explanation": "This presentation is consistent with macrophage activation syndrome (MAS), a life-threatening complication in rheumatic diseases like juvenile idiopathic arthritis, often triggered by biologic agents such as etanercept. Discontinuing the offending agent and starting high-dose corticosteroids is the initial management to control the cytokine storm. Bone marrow biopsy may confirm hemophagocytosis but is not the immediate next step, and antibiotics are inappropriate without evidence of infection.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues include a 14-year-old with juvenile idiopathic arthritis developing acute fever, rash, joint swelling post-etanercept initiation, with labs showing elevated ferritin, pancytopenia, and hypertriglyceridemia—these strongly suggest macrophage activation syndrome (MAS), a severe complication in rheumatic diseases triggered by biologics. The stem drives a unique best answer by highlighting classic MAS features without infection evidence or alternative diagnoses. No main logical issues; the vignette is coherent, supports one defensible best option (A), and the key matches it without contradictions or underspecification. No main medical accuracy issues; the implied management aligns with current guidelines for MAS, emphasizing discontinuation of the trigger and high-dose corticosteroids as initial steps to manage cytokine storm, consistent with pediatric rheumatology standards (e.g., HLH-2004 criteria adapted for MAS). Alternatives are appropriately inferior: B (IVIG not first-line), C (rituximab irrelevant), D (biopsy confirmatory but not immediate), E (antibiotics unwarranted absent infection). Minimal fix: No edit needed; item is unambiguous and accurate as written.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues include a 14-year-old with juvenile idiopathic arthritis developing acute fever, rash, joint swelling post-etanercept initiation, with labs showing elevated ferritin, pancytopenia, and hypertriglyceridemia—these strongly suggest macrophage activation syndrome (MAS), a severe complication in rheumatic diseases triggered by biologics. The stem drives a unique best answer by highlighting classic MAS features without infection evidence or alternative diagnoses. No main logical issues; the vignette is coherent, supports one defensible best option (A), and the key matches it without contradictions or underspecification. No main medical accuracy issues; the implied management aligns with current guidelines for MAS, emphasizing discontinuation of the trigger and high-dose corticosteroids as initial steps to manage cytokine storm, consistent with pediatric rheumatology standards (e.g., HLH-2004 criteria adapted for MAS). Alternatives are appropriately inferior: B (IVIG not first-line), C (rituximab irrelevant), D (biopsy confirmatory but not immediate), E (antibiotics unwarranted absent infection). Minimal fix: No edit needed; item is unambiguous and accurate as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-002", "question": "A 65-year-old man with hypertrophic cardiomyopathy develops sudden syncope during exercise. Echocardiography shows left ventricular outflow tract obstruction with a gradient of 80 mmHg. Despite beta-blocker therapy, symptoms persist. What is the most definitive management option?", "options": ["Surgical septal myectomy", "Alcohol septal ablation", "Implantable cardioverter-defibrillator placement", "Dual-chamber pacing", "Verapamil initiation"], "answer": "A", "answer_index": 0, "explanation": "Surgical septal myectomy is the gold standard for symptomatic hypertrophic cardiomyopathy with severe outflow tract obstruction refractory to medical therapy, offering superior long-term outcomes in experienced centers. Alcohol septal ablation is an alternative but carries risks like heart block and is less effective in younger patients. ICD placement addresses arrhythmic risk but not the obstruction itself.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include a 65-year-old with hypertrophic cardiomyopathy (HCM), sudden syncope during exercise, echocardiography showing left ventricular outflow tract (LVOT) obstruction with 80 mmHg gradient, and persistent symptoms despite beta-blocker therapy. These indicate severe symptomatic obstructive HCM refractory to medical management, pointing to septal reduction therapy as the next step. The question asks for the most definitive management, making surgical septal myectomy (A) the gold standard per ACC/AHA guidelines, offering superior long-term symptom relief and outcomes in experienced centers. No main logical issues; the stem provides sufficient details to discriminate options without contradictions or underspecification, supporting A as uniquely best. Alternatives are inferior: B (alcohol septal ablation) is an alternative for poor surgical candidates but less definitive with risks like heart block; C (ICD) addresses arrhythmic risk, not obstruction; D (dual-chamber pacing) is outdated and less effective; E (verapamil) is additional medical therapy, inappropriate for refractory cases. No main medical accuracy issues; aligns with current mainstream standards, including guideline recommendations for myectomy in suitable patients. Minimal fix: None needed; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include a 65-year-old with hypertrophic cardiomyopathy (HCM), sudden syncope during exercise, echocardiography showing left ventricular outflow tract (LVOT) obstruction with 80 mmHg gradient, and persistent symptoms despite beta-blocker therapy. These indicate severe symptomatic obstructive HCM refractory to medical management, pointing to septal reduction therapy as the next step. The question asks for the most definitive management, making surgical septal myectomy (A) the gold standard per ACC/AHA guidelines, offering superior long-term symptom relief and outcomes in experienced centers. No main logical issues; the stem provides sufficient details to discriminate options without contradictions or underspecification, supporting A as uniquely best. Alternatives are inferior: B (alcohol septal ablation) is an alternative for poor surgical candidates but less definitive with risks like heart block; C (ICD) addresses arrhythmic risk, not obstruction; D (dual-chamber pacing) is outdated and less effective; E (verapamil) is additional medical therapy, inappropriate for refractory cases. No main medical accuracy issues; aligns with current mainstream standards, including guideline recommendations for myectomy in suitable patients. Minimal fix: None needed; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-003", "question": "A term neonate develops respiratory distress and hypotension shortly after birth. Physical exam reveals hepatomegaly and poor perfusion. Echocardiogram shows dilated cardiomyopathy. Maternal history includes untreated systemic lupus erythematosus. What is the underlying mechanism?", "options": ["Transplacental passage of anti-Ro/SSA antibodies causing atrioventricular block", "Congenital viral infection leading to myocarditis", "Inborn error of metabolism affecting cardiac function", "Asphyxia-induced hypoxic cardiomyopathy", "Genetic mutation in sarcomeric proteins"], "answer": "A", "answer_index": 0, "explanation": "Neonatal lupus from maternal anti-Ro/SSA antibodies can cause complete heart block and cardiomyopathy, leading to heart failure in the newborn. This is distinct from viral myocarditis, which typically presents later and lacks the maternal autoimmune history. Metabolic or genetic causes are less likely without additional syndromic features.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues that drive a unique best answer: Term neonate with immediate post-birth respiratory distress, hypotension, hepatomegaly, poor perfusion, and echocardiographic dilated cardiomyopathy; maternal untreated systemic lupus erythematosus (SLE) strongly implicates autoimmune etiology. These findings (congestive heart failure signs plus maternal SLE) point uniquely to neonatal lupus via anti-Ro/SSA antibodies causing AV block and cardiomyopathy, distinguishing from alternatives lacking supportive clues like viral symptoms (B), metabolic errors (C), asphyxia (D), or genetic features (E).\\nMain logical issue(s), if any: None; vignette is internally consistent, supports single best answer A without contradictions or underspecification, and options allow clear discrimination.\\nMain medical accuracy issue(s), if any: None; aligns with current standards on neonatal lupus erythematosus, where maternal anti-Ro/SSA antibodies cross the placenta, causing fetal cardiac damage including complete heart block and dilated cardiomyopathy, leading to heart failure. This is a board-relevant teaching point without inaccuracies or outdated elements.\\nMinimal fix: No fix required; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues that drive a unique best answer: Term neonate with immediate post-birth respiratory distress, hypotension, hepatomegaly, poor perfusion, and echocardiographic dilated cardiomyopathy; maternal untreated systemic lupus erythematosus (SLE) strongly implicates autoimmune etiology. These findings (congestive heart failure signs plus maternal SLE) point uniquely to neonatal lupus via anti-Ro/SSA antibodies causing AV block and cardiomyopathy, distinguishing from alternatives lacking supportive clues like viral symptoms (B), metabolic errors (C), asphyxia (D), or genetic features (E).\nMain logical issue(s), if any: None; vignette is internally consistent, supports single best answer A without contradictions or underspecification, and options allow clear discrimination.\nMain medical accuracy issue(s), if any: None; aligns with current standards on neonatal lupus erythematosus, where maternal anti-Ro/SSA antibodies cross the placenta, causing fetal cardiac damage including complete heart block and dilated cardiomyopathy, leading to heart failure. This is a board-relevant teaching point without inaccuracies or outdated elements.\nMinimal fix: No fix required; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-004", "question": "A 28-year-old woman at 32 weeks gestation presents with severe preeclampsia and acute dyspnea. Echocardiography reveals peripartum cardiomyopathy with ejection fraction of 30%. What is the most critical intervention to improve maternal outcomes?", "options": ["Immediate delivery via cesarean section", "Initiate bromocriptine to suppress prolactin", "Administer intravenous furosemide and vasodilators", "Start anticoagulation with low-molecular-weight heparin", "Perform urgent cardiac transplantation evaluation"], "answer": "B", "answer_index": 1, "explanation": "Bromocriptine inhibits prolactin, which is implicated in the pathogenesis of peripartum cardiomyopathy, and has shown benefit in improving left ventricular function when added to standard heart failure therapy. Immediate delivery may be necessary for preeclampsia but does not directly address cardiomyopathy. Diuretics and vasodilators manage symptoms but are not disease-modifying in this context.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: M (primary; secondary U). Verdict on keyed answer: Not uniquely determinable. Key stem clues: 28-year-old at 32 weeks gestation with severe preeclampsia, acute dyspnea, and echocardiography-confirmed peripartum cardiomyopathy (PPCM) with ejection fraction 30%, implying urgent need to address both hypertensive emergency and heart failure. Main logical issue(s): The stem is underspecified regarding priority between preeclampsia management and PPCM-specific therapy, leading to multiple defensible answers—A (immediate delivery as definitive for severe preeclampsia at viable gestation, potentially improving maternal hemodynamics) and C (IV furosemide and vasodilators for acute decompensated heart failure causing dyspnea) are equally reasonable as 'most critical' for maternal outcomes; B requires assuming prolactin inhibition is paramount despite overlapping urgencies. No contradictions, but ambiguity prevents a unique best. Main medical accuracy issue(s): Bromocriptine is supported by some evidence (e.g., trials showing LV recovery in PPCM via prolactin suppression) and ESC guidelines as possible add-on, but it is not the most critical intervention per mainstream standards (ACOG/NICE prioritize stabilization and delivery for severe preeclampsia with HF); rationale overstates it as primary disease-modifying over symptom management/delivery. Minimal fix: Revise stem to 'After initial stabilization and delivery, what is the most appropriate adjunct therapy for PPCM?' and key to B.\",\n  \"medical_accuracy_score\": 3,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"M\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (primary; secondary U). Verdict on keyed answer: Not uniquely determinable. Key stem clues: 28-year-old at 32 weeks gestation with severe preeclampsia, acute dyspnea, and echocardiography-confirmed peripartum cardiomyopathy (PPCM) with ejection fraction 30%, implying urgent need to address both hypertensive emergency and heart failure. Main logical issue(s): The stem is underspecified regarding priority between preeclampsia management and PPCM-specific therapy, leading to multiple defensible answers—A (immediate delivery as definitive for severe preeclampsia at viable gestation, potentially improving maternal hemodynamics) and C (IV furosemide and vasodilators for acute decompensated heart failure causing dyspnea) are equally reasonable as 'most critical' for maternal outcomes; B requires assuming prolactin inhibition is paramount despite overlapping urgencies. No contradictions, but ambiguity prevents a unique best. Main medical accuracy issue(s): Bromocriptine is supported by some evidence (e.g., trials showing LV recovery in PPCM via prolactin suppression) and ESC guidelines as possible add-on, but it is not the most critical intervention per mainstream standards (ACOG/NICE prioritize stabilization and delivery for severe preeclampsia with HF); rationale overstates it as primary disease-modifying over symptom management/delivery. Minimal fix: Revise stem to 'After initial stabilization and delivery, what is the most appropriate adjunct therapy for PPCM?' and key to B.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-005", "question": "In the ICU, a 55-year-old patient with septic shock on vasopressors develops acute kidney injury and metabolic acidosis. Despite fluid resuscitation, oliguria persists. Continuous renal replacement therapy is initiated. What is the most appropriate modality to optimize hemodynamic stability?", "options": ["Continuous venovenous hemodiafiltration with citrate anticoagulation", "Intermittent hemodialysis with bicarbonate buffer", "Sustained low-efficiency dialysis", "Peritoneal dialysis", "Continuous venovenous hemofiltration alone"], "answer": "A", "answer_index": 0, "explanation": "Continuous venovenous hemodiafiltration (CVVHDF) provides both convective and diffusive clearance, making it ideal for septic shock with acidosis, and citrate anticoagulation minimizes clotting while providing regional effects. Intermittent hemodialysis can cause hemodynamic instability in critically ill patients. Peritoneal dialysis is less efficient for rapid toxin removal in this setting.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include septic shock on vasopressors, acute kidney injury with persistent oliguria despite fluids, metabolic acidosis, and ICU setting requiring CRRT for hemodynamic stability. These point to a continuous modality that balances clearance and stability without rapid shifts. The question asks for the optimal CRRT modality to optimize hemodynamic stability in this critically ill patient. Discriminating findings: vasopressor dependence implies need for gradual solute/fluid removal; acidosis suggests effective clearance of acids; oliguria indicates need for efficient filtration/dialysis. Most likely next step: CVVHDF with citrate, providing both convective and diffusive clearance plus regional anticoagulation to minimize systemic effects and clotting. Keyed answer A fits: combines convection/diffusion for acidosis correction, citrate enhances stability in shock. Alternatives: B (intermittent HD) risks instability from rapid changes; C (SLED) is less continuous, potentially less stable; D (PD) inefficient for rapid ICU needs; E (CVVH alone) lacks diffusion, suboptimal for acidosis. No main logical issues; stem is consistent and specifies enough for discrimination without assumptions. No main medical accuracy issues; aligns with KDIGO guidelines favoring CRRT like CVVHDF in hemodynamically unstable AKI with acidosis, citrate preferred for anticoagulation. Minimal fix: None needed, item is unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include septic shock on vasopressors, acute kidney injury with persistent oliguria despite fluids, metabolic acidosis, and ICU setting requiring CRRT for hemodynamic stability. These point to a continuous modality that balances clearance and stability without rapid shifts. The question asks for the optimal CRRT modality to optimize hemodynamic stability in this critically ill patient. Discriminating findings: vasopressor dependence implies need for gradual solute/fluid removal; acidosis suggests effective clearance of acids; oliguria indicates need for efficient filtration/dialysis. Most likely next step: CVVHDF with citrate, providing both convective and diffusive clearance plus regional anticoagulation to minimize systemic effects and clotting. Keyed answer A fits: combines convection/diffusion for acidosis correction, citrate enhances stability in shock. Alternatives: B (intermittent HD) risks instability from rapid changes; C (SLED) is less continuous, potentially less stable; D (PD) inefficient for rapid ICU needs; E (CVVH alone) lacks diffusion, suboptimal for acidosis. No main logical issues; stem is consistent and specifies enough for discrimination without assumptions. No main medical accuracy issues; aligns with KDIGO guidelines favoring CRRT like CVVHDF in hemodynamically unstable AKI with acidosis, citrate preferred for anticoagulation. Minimal fix: None needed, item is unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-006", "question": "A 45-year-old woman with rheumatoid arthritis on methotrexate develops progressive dyspnea and dry cough. High-resolution CT shows subpleural reticular opacities and traction bronchiectasis. Pulmonary function tests reveal restrictive pattern. What is the most likely diagnosis?", "options": ["Methotrexate-induced interstitial lung disease", "Rheumatoid arthritis-associated usual interstitial pneumonia", "Hypersensitivity pneumonitis from environmental exposure", "Non-specific interstitial pneumonia", "Cryptogenic organizing pneumonia"], "answer": "B", "answer_index": 1, "explanation": "Rheumatoid arthritis can cause interstitial lung disease with a usual interstitial pneumonia pattern, which is more common than methotrexate toxicity in long-term users. Methotrexate-induced ILD typically presents acutely and improves upon discontinuation, unlike this progressive course. Hypersensitivity pneumonitis would show upper lobe predominance and different triggers.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include progressive dyspnea and dry cough in a 45-year-old woman with rheumatoid arthritis (RA) on methotrexate, high-resolution CT showing subpleural reticular opacities and traction bronchiectasis (classic for usual interstitial pneumonia, UIP), and restrictive pulmonary function tests. These findings point to RA-associated UIP as the most likely diagnosis, as RA commonly causes ILD with UIP pattern, which is fibrotic and progressive. The keyed answer B fits perfectly, supported by the subpleural distribution and traction bronchiectasis without needing assumptions. Alternatives are inferior: A (methotrexate-induced ILD) is typically acute and reversible, not matching the progressive course; C (hypersensitivity pneumonitis) shows upper lobe predominance and centrilobular nodules, not subpleural reticular changes; D (non-specific interstitial pneumonia) features more ground-glass opacities and less fibrosis; E (cryptogenic organizing pneumonia) presents with consolidations, not reticular patterns. No main logical issues; the stem is consistent and specifies details allowing discrimination of one best option. No main medical accuracy issues; aligns with current guidelines (e.g., ATS/ERS) on RA-ILD patterns, where UIP is prevalent and distinguished from drug-induced ILD by chronicity. Minimal fix: None required, as the item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include progressive dyspnea and dry cough in a 45-year-old woman with rheumatoid arthritis (RA) on methotrexate, high-resolution CT showing subpleural reticular opacities and traction bronchiectasis (classic for usual interstitial pneumonia, UIP), and restrictive pulmonary function tests. These findings point to RA-associated UIP as the most likely diagnosis, as RA commonly causes ILD with UIP pattern, which is fibrotic and progressive. The keyed answer B fits perfectly, supported by the subpleural distribution and traction bronchiectasis without needing assumptions. Alternatives are inferior: A (methotrexate-induced ILD) is typically acute and reversible, not matching the progressive course; C (hypersensitivity pneumonitis) shows upper lobe predominance and centrilobular nodules, not subpleural reticular changes; D (non-specific interstitial pneumonia) features more ground-glass opacities and less fibrosis; E (cryptogenic organizing pneumonia) presents with consolidations, not reticular patterns. No main logical issues; the stem is consistent and specifies details allowing discrimination of one best option. No main medical accuracy issues; aligns with current guidelines (e.g., ATS/ERS) on RA-ILD patterns, where UIP is prevalent and distinguished from drug-induced ILD by chronicity. Minimal fix: None required, as the item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-007", "question": "A 2-year-old child with hypoplastic left heart syndrome post-Norwood procedure presents with cyanosis and metabolic acidosis. Echocardiography shows right ventricular dysfunction and tricuspid regurgitation. What is the most appropriate pharmacologic intervention?", "options": ["Milrinone infusion for inotropic support", "Prostaglandin E1 to maintain ductal patency", "Sildenafil for pulmonary hypertension", "Digoxin for rate control", "Epinephrine bolus for hypotension"], "answer": "A", "answer_index": 0, "explanation": "Milrinone provides inotropic support and pulmonary vasodilation, crucial for right ventricular failure in single-ventricle physiology after Norwood. Prostaglandin E1 is used preoperatively but not post-Norwood. Sildenafil targets pulmonary hypertension but lacks the inotropic effect needed here.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include post-Norwood HLHS with cyanosis, metabolic acidosis, RV dysfunction, and tricuspid regurgitation, implying right heart failure in single-ventricle physiology requiring inotropic support with vasodilatory benefits. Main logical issue(s): none; the vignette provides sufficient discriminating findings (e.g., RV dysfunction without mention of ductal dependency, pulmonary hypertension, arrhythmia, or hypotension) to identify milrinone as uniquely best, eliminating alternatives logically. Main medical accuracy issue(s): none; milrinone's use for inotropic support and pulmonary vasodilation aligns with current guidelines for managing RV failure post-Norwood in HLHS, consistent with pediatric cardiology standards (e.g., AHA recommendations). The rationale correctly notes PGE1's preoperative role and sildenafil's limitations without inotropy. Alternatives are appropriately inferior: PGE1 irrelevant post-shunt; sildenafil lacks needed inotropy; digoxin for unmentioned rate issues; epinephrine bolus unsuitable without specified hypotension. Minimal fix: No edit needed; item is unambiguous and accurate as written.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include post-Norwood HLHS with cyanosis, metabolic acidosis, RV dysfunction, and tricuspid regurgitation, implying right heart failure in single-ventricle physiology requiring inotropic support with vasodilatory benefits. Main logical issue(s): none; the vignette provides sufficient discriminating findings (e.g., RV dysfunction without mention of ductal dependency, pulmonary hypertension, arrhythmia, or hypotension) to identify milrinone as uniquely best, eliminating alternatives logically. Main medical accuracy issue(s): none; milrinone's use for inotropic support and pulmonary vasodilation aligns with current guidelines for managing RV failure post-Norwood in HLHS, consistent with pediatric cardiology standards (e.g., AHA recommendations). The rationale correctly notes PGE1's preoperative role and sildenafil's limitations without inotropy. Alternatives are appropriately inferior: PGE1 irrelevant post-shunt; sildenafil lacks needed inotropy; digoxin for unmentioned rate issues; epinephrine bolus unsuitable without specified hypotension. Minimal fix: No edit needed; item is unambiguous and accurate as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-008", "question": "A 70-year-old man with atrial fibrillation on anticoagulation develops acute chest pain and hypotension. Coronary angiography shows no obstructive disease, but left ventriculography reveals apical ballooning. What is the underlying pathophysiology?", "options": ["Catecholamine surge leading to transient myocardial stunning", "Spontaneous coronary artery dissection", "Myocarditis from viral infection", "Embolic occlusion of distal coronaries", "Vasospasm induced by ergonovine"], "answer": "A", "answer_index": 0, "explanation": "Takotsubo cardiomyopathy involves catecholamine-mediated myocardial stunning, mimicking acute coronary syndrome without angiographic abnormalities. Dissection would show vessel irregularities on angiography. Myocarditis typically presents with inflammatory markers and different ventricular patterns.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include acute chest pain and hypotension in a 70-year-old with atrial fibrillation on anticoagulation, coronary angiography showing no obstructive disease, and left ventriculography revealing apical ballooning. These findings classically point to Takotsubo cardiomyopathy, where the underlying pathophysiology is a catecholamine surge causing transient myocardial stunning (option A). The absence of obstructive disease rules out embolic occlusion (D) or dissection (B), which would show angiographic abnormalities. Myocarditis (C) typically involves inflammatory markers and different ventricular patterns, not specified here. Vasospasm (E) is linked to ergonovine provocation, not mentioned. The stem provides sufficient discriminating details—no missing critical facts—to identify A as the unique best answer without unstated assumptions. Main logical issue(s): none; the item is coherent, with options permitting clear discrimination. Main medical accuracy issue(s): none; the keyed answer aligns with current mainstream understanding of Takotsubo cardiomyopathy as catecholamine-mediated stunning, mimicking ACS without coronary lesions, per guidelines like those from the American Heart Association. Minimal fix: none required, as the item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include acute chest pain and hypotension in a 70-year-old with atrial fibrillation on anticoagulation, coronary angiography showing no obstructive disease, and left ventriculography revealing apical ballooning. These findings classically point to Takotsubo cardiomyopathy, where the underlying pathophysiology is a catecholamine surge causing transient myocardial stunning (option A). The absence of obstructive disease rules out embolic occlusion (D) or dissection (B), which would show angiographic abnormalities. Myocarditis (C) typically involves inflammatory markers and different ventricular patterns, not specified here. Vasospasm (E) is linked to ergonovine provocation, not mentioned. The stem provides sufficient discriminating details—no missing critical facts—to identify A as the unique best answer without unstated assumptions. Main logical issue(s): none; the item is coherent, with options permitting clear discrimination. Main medical accuracy issue(s): none; the keyed answer aligns with current mainstream understanding of Takotsubo cardiomyopathy as catecholamine-mediated stunning, mimicking ACS without coronary lesions, per guidelines like those from the American Heart Association. Minimal fix: none required, as the item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-009", "question": "A 35-year-old pregnant woman at 28 weeks with antiphospholipid syndrome develops thrombocytopenia and elevated liver enzymes. Fetal monitoring shows growth restriction. What is the most appropriate management strategy?", "options": ["Low-dose aspirin and low-molecular-weight heparin continuation with close monitoring", "Immediate delivery to prevent maternal deterioration", "Plasmapheresis for antibody removal", "Intravenous immunoglobulin infusion", "Switch to unfractionated heparin"], "answer": "A", "answer_index": 0, "explanation": "In antiphospholipid syndrome during pregnancy, continuing low-dose aspirin and LMWH is standard to manage thrombotic risks and prevent complications like HELLP-like syndrome, with vigilant monitoring. Immediate delivery is premature at 28 weeks without severe features. IVIG is not first-line and reserved for refractory cases.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 35-year-old at 28 weeks gestation with antiphospholipid syndrome (APS), developing thrombocytopenia, elevated liver enzymes, and fetal growth restriction—these suggest possible HELLP-like syndrome or APS complications, but without specified severe features like profound thrombocytopenia, significant hemolysis, hypertension, or maternal/fetal distress, driving conservative management. Main logical issue(s): None; stem provides sufficient details to discriminate options without contradictions or underspecification, supporting A as uniquely best via standard APS pregnancy protocols emphasizing anticoagulation continuation and monitoring to mitigate thrombotic risks. Main medical accuracy issue(s): None; aligns with current guidelines (e.g., ACOG, EULAR) recommending low-dose aspirin and LMWH for APS in pregnancy to prevent preeclampsia-like syndromes and fetal growth issues, with delivery reserved for severe deterioration; alternatives like immediate delivery risk prematurity without indications, while plasmapheresis, IVIG, or heparin switch lack first-line evidence. Minimal fix: No edit needed; item is already unambiguous and accurate, though adding 'mild thrombocytopenia and moderately elevated liver enzymes without hemolysis or hypertension' could enhance clarity without altering intent.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 35-year-old at 28 weeks gestation with antiphospholipid syndrome (APS), developing thrombocytopenia, elevated liver enzymes, and fetal growth restriction—these suggest possible HELLP-like syndrome or APS complications, but without specified severe features like profound thrombocytopenia, significant hemolysis, hypertension, or maternal/fetal distress, driving conservative management. Main logical issue(s): None; stem provides sufficient details to discriminate options without contradictions or underspecification, supporting A as uniquely best via standard APS pregnancy protocols emphasizing anticoagulation continuation and monitoring to mitigate thrombotic risks. Main medical accuracy issue(s): None; aligns with current guidelines (e.g., ACOG, EULAR) recommending low-dose aspirin and LMWH for APS in pregnancy to prevent preeclampsia-like syndromes and fetal growth issues, with delivery reserved for severe deterioration; alternatives like immediate delivery risk prematurity without indications, while plasmapheresis, IVIG, or heparin switch lack first-line evidence. Minimal fix: No edit needed; item is already unambiguous and accurate, though adding 'mild thrombocytopenia and moderately elevated liver enzymes without hemolysis or hypertension' could enhance clarity without altering intent.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-010", "question": "In the critical care unit, a 60-year-old patient with acute respiratory distress syndrome on mechanical ventilation develops refractory hypoxemia despite prone positioning. Extracorporeal membrane oxygenation is considered. What is the primary indication for venovenous ECMO in this scenario?", "options": ["PaO2/FiO2 ratio less than 80 with FiO2 greater than 90%", "Hypercapnia unresponsive to increased minute ventilation", "Right ventricular failure on echocardiography", "Sepsis-induced myocardial depression", "Barotrauma from high plateau pressures"], "answer": "A", "answer_index": 0, "explanation": "Venovenous ECMO is indicated for severe ARDS when PaO2/FiO2 <80 on FiO2 >90%, despite optimal ventilatory support, to provide gas exchange. Hypercapnia alone may be managed with permissive strategies or ECCO2R. Right ventricular failure would prompt venoarterial ECMO consideration instead.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include a 60-year-old with ARDS on mechanical ventilation developing refractory hypoxemia despite prone positioning, implying severe hypoxemic respiratory failure unresponsive to conventional management. This scenario directly aligns with indications for venovenous (VV) ECMO, specifically severe ARDS with PaO2/FiO2 <80 on FiO2 >90%, as per EOLIA trial criteria and mainstream guidelines, making A the unique best. Main logical issue(s): none; the stem provides sufficient details to discriminate without contradictions or underspecification, as refractory hypoxemia points to gas exchange support via VV ECMO, while alternatives address different complications (e.g., B for hypercapnia manageable by other means, C/D for cardiac issues warranting venoarterial ECMO, E for ventilator-induced injury not primarily indicating ECMO). Main medical accuracy issue(s): none; the item reflects current standards from ECMO guidelines (e.g., ELSO), with accurate pathophysiology (VV for oxygenation/CO2 removal in isolated lung failure) and avoids outdated concepts. Minimal fix: none required, as the item is already unambiguous and accurate; optionally, add 'despite optimal ventilatory support' to stem for explicit reinforcement.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include a 60-year-old with ARDS on mechanical ventilation developing refractory hypoxemia despite prone positioning, implying severe hypoxemic respiratory failure unresponsive to conventional management. This scenario directly aligns with indications for venovenous (VV) ECMO, specifically severe ARDS with PaO2/FiO2 <80 on FiO2 >90%, as per EOLIA trial criteria and mainstream guidelines, making A the unique best. Main logical issue(s): none; the stem provides sufficient details to discriminate without contradictions or underspecification, as refractory hypoxemia points to gas exchange support via VV ECMO, while alternatives address different complications (e.g., B for hypercapnia manageable by other means, C/D for cardiac issues warranting venoarterial ECMO, E for ventilator-induced injury not primarily indicating ECMO). Main medical accuracy issue(s): none; the item reflects current standards from ECMO guidelines (e.g., ELSO), with accurate pathophysiology (VV for oxygenation/CO2 removal in isolated lung failure) and avoids outdated concepts. Minimal fix: none required, as the item is already unambiguous and accurate; optionally, add 'despite optimal ventilatory support' to stem for explicit reinforcement.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]